Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
Bristol Myers Squibb to Acquire Mirati Therapeutics in Deal Worth Up to $5.8 Billion
The deal expands the pharmaceutical company’s portfolio of cancer drugs. Source link
Family of Henrietta Lacks, Whose Unique Cells Changed Science, Settles With Thermo Fisher
What to Read Next Source link
Venture Capitalist Seeks to Spur Drug Development for Rare Autoimmune Disease
Venture capitalist Luke Evnin has financed several successful biotechnology startups that develop treatments for cancer. Now he is encouraging drugmakers to tackle another disease: a rare autoimmune condition that
Alzheimer’s diagnosis revamp embraces rating scale similar to cancer By Reuters
© Reuters. FILE PHOTO: Dr. Seth Gale points out evidence of Alzheimer?s disease on PET scans at the Center for Alzheimer Research and Treatment (CART)
Drugs Like Ozempic Created a Gold Rush. These Drugmakers Want In.
Companies developing weight-loss drugs have raised or made deals valued at more than $1.4 billion since about a year ago. Source link
Johnson & Johnson Sues Doctors Over Studies Linking Talc-Based Products and Cancer
Company says the studies played a significant role in lawsuits over its Baby Powder and Shower to Shower products. Source link
The Longevity Clinic Will See You Now—for $100,000
The clinics cater to a growing number of people obsessed with fighting aging. Source link
Moderna, Merck Show Progress Toward Cancer Vaccines
An mRNA shot helped prevent relapse in high-risk melanoma patients. Source link
Johnson & Johnson’s Talc Plan Spotlights Chapter 11 Voting Power
Johnson & Johnson’s latest plan to resolve mass cancer lawsuits through bankruptcy could force some cosmetic-talc users and their lawyers into a settlement they don’t
AstraZeneca : Lynparza Combination Improves PFS In Phase III Ovarian Cancer Trial
(RTTNews) – British drug major AstraZeneca Plc (AZN, AZN.L) said results from an interim analysis of the DUO-O Phase III trial showed treatment with a
